STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

VSTM 8-K: Corporate Presentation Filed on Sept 8, 2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Verastem, Inc. submitted an 8-K reporting a material event: the company furnished a Corporate Presentation dated September 8, 2025. The filing identifies the company common stock symbol VSTM listed on The Nasdaq Capital Market and is signed by Chief Executive Officer Daniel W. Paterson. The cover references communications categories under Securities Act and Exchange Act rules including written communications under Rule 425 and pre‑commencement/soliciting communications under Rules 14a-12, 14d-2(b), and 13e-4(c). No financial tables, earnings figures, transactions, or additional narrative details appear in the provided text.

Positive

  • Corporate Presentation dated September 8, 2025 was furnished, ensuring material communications are disclosed
  • Signed by CEO Daniel W. Paterson, confirming executive attestation of the filing

Negative

  • None.

Insights

Company furnished a corporate presentation dated September 8, 2025.

The filing indicates a formal disclosure of a Corporate Presentation and checks communication categories consistent with proxy/transaction pre‑commencement and written communications rules. This typically signals outreach to investors or counterparties using prepared investor materials.

Dependencies and risks include how the presentation content may affect investor perception; there are no earnings, transaction, or forward guidance details included here. Monitor any subsequent filings or public distribution of the presentation for material facts or deal terms within the next few trading sessions.

false 0001526119 0001526119 2025-09-08 2025-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 8, 2025

 

Verastem, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-35403   27-3269467
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

117 Kendrick Street, Suite 500, Needham, MA   02494
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (781) 292-4200

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
Common stock, $0.0001 par value per share   VSTM   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure

 

On September 8, 2025, Verastem, Inc. posted its updated corporate presentation on its website, a copy of which is furnished hereto as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.   Description
99.1   Corporate Presentation, dated September 8, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VERASTEM, INC.
     
Dated: September 8, 2025 By: /s/ Daniel W. Paterson
    Daniel W. Paterson
    Chief Executive Officer

 

 

 

FAQ

What did Verastem (VSTM) file on September 8, 2025?

Verastem filed an 8-K furnishing a Corporate Presentation dated September 8, 2025 and identified communication categories under Rules 425, 14a-12, 14d-2(b), and 13e-4(c).

Does the filing include financial results or transaction terms for VSTM?

No. The provided content contains no financial tables, earnings data, or transaction details.

Who signed the 8-K for Verastem (VSTM)?

The filing is signed by Daniel W. Paterson, Chief Executive Officer.

Which exchange lists Verastem common stock?

Verastem common stock (symbol VSTM) is listed on The Nasdaq Capital Market.

Are there immediate investor actions disclosed in this 8-K?

The document only furnishes a corporate presentation; it does not disclose any definitive transactions, timelines, or investor actions.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

801.40M
70.82M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM